VEDANTA PARTNERS, LLC - 01 Jun 2021 Form 3 Insider Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Reporting relationship: 10%+ Owner
Issuer ticker: RVPH
Reported as of: 01 Jun 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 03 Jun 2021, 17:29:59 UTC
Next SEC filing: 12 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Parag Saxena - for Vedanta Partners, LLC, by Parag Saxena, its CEO

Filing notes and source

Key filing fact

VEDANTA PARTNERS, LLC filed Form 3 for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) on 03 Jun 2021.

Key facts

This page summarizes VEDANTA PARTNERS, LLC's Form 3 filing for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2021, 17:29.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVPH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 99,539
Date: 01 Jun 2021
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Held directly by Vedanta Associates, L.P. ("Vedanta Associates"). Vedanta Partners, LLC ("Vedanta Partners") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported herein, except to the extent of any pecuniary interest therein.